Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
2,396.00
2,080.00
1,830.00
1,655.00
1,482.00
709.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
2,396.00
2,080.00
1,830.00
1,655.00
1,482.00
709.00
Expenditure (Ex Depriciation)
Stock Adjustments
-28.00
-31.00
-63.00
-12.00
-20.00
-8.00
Raw Materials Consumed
1,697.00
1,464.00
1,357.00
1,183.00
1,125.00
470.00
Power & Fuel Cost
26.00
25.00
0.00
0.00
0.00
0.00
Employee Cost
154.00
132.00
103.00
98.00
67.00
41.00
Operating Expenses
130.00
112.00
86.00
72.00
64.00
31.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
35.00
33.00
18.00
22.00
12.00
21.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
12.00
13.00
12.00
10.00
12.00
10.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
2,110.00
1,815.00
1,580.00
1,432.00
1,299.00
585.00
Operating Profit (PBDIT) excl Other Income
285.00
265.00
249.00
223.00
183.00
123.00
Other Income
22.00
4.00
7.00
5.00
11.00
8.00
Operating Profit (PBDIT)
308.00
269.00
257.00
228.00
195.00
132.00
Interest
28.00
17.00
19.00
22.00
12.00
2.00
Profit before Depriciation and Tax
279.00
251.00
237.00
206.00
182.00
129.00
Depreciation
79.00
67.00
60.00
62.00
48.00
22.00
Profit Before Taxation & Exceptional Items
200.00
184.00
177.00
143.00
134.00
106.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
202.00
185.00
177.00
144.00
136.00
106.00
Provision for Tax
53.00
48.00
46.00
36.00
38.00
26.00
Profit After Tax
147.00
135.00
130.00
106.00
96.00
79.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
697.00
564.00
436.00
331.00
238.00
160.00
Profit Available for appropriations
846.00
700.00
567.00
439.00
336.00
241.00
Appropriations
846.00
700.00
567.00
439.00
336.00
241.00
Equity Dividend (%)
25.00%
25.00%
25.00%
25.00%
25.00%
25.00%
Earnings Per Share
26.95
24.66
23.67
19.46
17.81
15.56
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 15.19% vs 13.64% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 7.85% vs 6.14% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 60.25% vs -8.06% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 8.80% vs 3.74% in Mar 2025
Compare Profit and Loss Results of Rossari Biotech
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2,396.00
1,276.00
1,120.00
87.77%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2,396.00
1,276.00
1,120.00
87.77%
Expenditure (Ex Depriciation)
Stock Adjustments
-28.00
-11.00
-17.00
-154.55%
Raw Materials Consumed
1,697.00
859.00
838.00
97.56%
Power & Fuel Cost
26.00
40.00
-14.00
-35.00%
Employee Cost
154.00
62.00
92.00
148.39%
Operating Expenses
130.00
16.00
114.00
712.50%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
35.00
35.00
0.00
0.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
12.00
24.00
-12.00
-50.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
2,110.00
1,059.00
1,051.00
99.24%
Operating Profit (PBDIT) excl Other Income
285.00
216.00
69.00
31.94%
Other Income
22.00
38.00
-16.00
-42.11%
Operating Profit (PBDIT)
308.00
255.00
53.00
20.78%
Interest
28.00
0.00
28.00
0%
Profit before Depriciation and Tax
279.00
255.00
24.00
9.41%
Depreciation
79.00
8.00
71.00
887.50%
Profit Before Taxation & Exceptional Items
200.00
246.00
-46.00
-18.70%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
202.00
247.00
-45.00
-18.22%
Provision for Tax
53.00
67.00
-14.00
-20.90%
Profit After Tax
147.00
179.00
-32.00
-17.88%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
697.00
953.00
-256.00
-26.86%
Profit Available for appropriations
846.00
1,133.00
-287.00
-25.33%
Appropriations
846.00
1,133.00
-287.00
-25.33%
Equity Dividend (%)
25%
400%
-375.00
Earnings Per Share
26.95
7.24
19.71
272.24%
Profit And Loss - Net Sales
Net Sales 2,396.36 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 15.19% vs 13.64% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 285.90 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 7.85% vs 6.14% in Mar 2025
Profit And Loss - Interest
Interest 28.54 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 60.25% vs -8.06% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 147.31 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 8.80% vs 3.74% in Mar 2025






